The Trump administration's moves to reduce government funding for the US Food and Drug Administration (FDA) and other ...

Swedish firm Alligator Bioscience (STO: ATORX) has announced that Dr Sumeet Ambarkhane, chief medical officer, will be ...

Danish biotech (Nasdaq: GMAB) on Saturday revealed that US pharma major (AbbVie (NYSE: ABBV) has filed a complaint in the US ...

US healthcare giant Johnson & Johnson has announced manufacturing, research and development and technology investments of ...

Dizal Pharmaceutical will present new research findings on two of its innovative drugs - sunvozertinib and golidacitinib - at ...

The New Drug Application (NDA) for Tazverik (tazemetostat) has been granted conditional approval in China for the treatment ...

Chinese biotech Akeso (HKEX: 9926) has reported encouraging early data from a Phase III trial of its bispecific antibody ...

China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries ...

The US Food and Drug Administration (FDA) has approved Swiss pharma giant Novartis’ (NOVN: VX) oral Fabhalta (iptacopan) for ...

Monte Rosa Therapeutics, a US biotech developing novel molecular glue degrader (MGD)-based medicines, closed Thursday’s ...

US pharma major Johnson & Johnson (NYSE: JNJ) has won US approval for Tremfya (guselkumab) in the treatment of adults with ...

US biotech Rhythm Pharmaceuticals (Nasdaq: RYTM) has reacquired the rights to its obesity treatment Imcivree (setmelanotide) ...